From 567b0b6f39b77dca798f28937279c3643c84297b Mon Sep 17 00:00:00 2001 From: borja Date: Thu, 31 Oct 2024 12:59:51 +0100 Subject: [PATCH] Auto saved by Logseq --- journals/2024_10_31.md | 4 +++- 1 file changed, 3 insertions(+), 1 deletion(-) diff --git a/journals/2024_10_31.md b/journals/2024_10_31.md index 1e1c22ea..a9f55dee 100644 --- a/journals/2024_10_31.md +++ b/journals/2024_10_31.md @@ -16,7 +16,9 @@ - Putting upfront all the progress made with our products (pzq and fdc). Show them briefly how we made the progres to create the evidence and make the regulatory agencies register. What is the need after we as researchers. There is still a gap between what we made and the program and recomendations. - WHO has included pzq in the prequalification list. It looks like we are stuck, but there is progress. - What are these implementation studies that take time and new investment thats the gap being tried to fill. Neither us or Maurice need to engage in how these drugs will be accessed. We're just setting the game for them to discuss. - - Stella agrees. + - Stella agrees. Its more showing the path that it takes for new products to be able to be sent out to the masses than the process where is now. + - Demonstrating that doing the pivotal trial and submit to regulatory agencies doesn't mean inclusion in programs. + - I got in touch with EDCTP authorities to highlight that PZQ and - ### Decisiones - - CANCELED 17:00 - 17:30: Pre-Symposium meeting